KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Current Deferred Revenue (2016 - 2021)

CareDx's Current Deferred Revenue history spans 9 years, with the latest figure at $4.2 million for Q4 2021.

  • On a quarterly basis, Current Deferred Revenue rose 19.21% to $4.2 million in Q4 2021 year-over-year; TTM through Dec 2021 was $4.2 million, a 19.21% increase, with the full-year FY2021 number at $4.2 million, up 19.21% from a year prior.
  • Current Deferred Revenue hit $4.2 million in Q4 2021 for CareDx, up from $3.4 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CDNA hit a ceiling of $4.2 million in Q4 2021 and a floor of $39000.0 in Q2 2017.
  • Historically, Current Deferred Revenue has averaged $1.9 million across 5 years, with a median of $1.8 million in 2017.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 90.69% in 2018 and later soared 9351.28% in 2019.
  • Tracing CDNA's Current Deferred Revenue over 5 years: stood at $419000.0 in 2017, then tumbled by 90.69% to $39000.0 in 2018, then soared by 9351.28% to $3.7 million in 2019, then decreased by 4.23% to $3.5 million in 2020, then increased by 19.21% to $4.2 million in 2021.
  • Business Quant data shows Current Deferred Revenue for CDNA at $4.2 million in Q4 2021, $3.4 million in Q3 2021, and $3.9 million in Q2 2021.